Abstract
Dengue hemmorhagic fever is a disease caused by Dengue Virus (DENV) infection that carried by mosquito vector. The incidence of DHF in Indonesia (2013) is 41.25 cases per 100,000 population. However, until now there is no antiviral therapy for DHF. Last report explained the anti-Dengue activity in Psidium guajava leaves extract that have potency to inhibits the DENV infection with IC50 7.2 μg/mL and CC50 153.18 μg/mL. But, the mechanism still unknown. This research measure the percentage of viral inhibition in the DENV surface protein inhibition and receptor inhibition of 2 times IC50 extract using focus assay methods and followed by measure of cell viability using MTT assay. The results of focus assay for DENV surface protein inhibition is 58.24 ± 17.40% and in DENV receptor inhibition is 8.56 ± 6.29%. Then, the cell viability of attachment and receptor inhibition are 100.71 ± 4.72% and 100.96 ± 3.51% The bioactive compounds in the extract that acts as anti-Dengue are querectin and hyperoside. But, the action of quercetin is not on DENV surface protein or inhibits the DENV receptors and hyperoside acts to inhibits DENV receptor. This novelty suggest maybe there are other compounds in Psidium guajava leaves extract that acts as anti-Dengue.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: IOP Conference Series: Earth and Environmental Science
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
